Why is Zenith Drugs falling/rising?

As of 18-Jul, Zenith Drugs Ltd's stock price is currently at 73.50, showing no change (0.00%). The stock has outperformed its sector by 0.55% today, and its performance over the past week and month has been positive, with returns of +5.00% and +7.61%, respectively. However, the stock has seen a decline of -9.03% year-to-date and -9.37% over the past year. The moving averages indicate that the stock is performing better than the 5-day, 20-day, 50-day, and 100-day averages, but it remains below the 200-day moving average. Additionally, there has been a significant drop in investor participation, with delivery volume falling by -42.53% against the 5-day average, which may indicate a lack of confidence among investors.
In the broader market context, Zenith Drugs has outperformed the Sensex by +5.72% over the past week, while the benchmark has declined by -0.72%. Despite this short-term outperformance, the stock's year-to-date performance is notably weaker compared to the Sensex, which has gained +5.60%. This contrast suggests that while the stock may be experiencing some positive momentum recently, its overall performance has lagged behind the market, contributing to a cautious outlook among investors. The absence of specific positive or negative factors further complicates the understanding of the stock's recent movements, leaving a gap in the analysis of its current trajectory.